Medpace Board approves $50M increase to share repurchase program

Medpace Holdings, Inc.

Board of Directors approved $50M increase to existing stock repurchase program on June 10, 2022.
Repurchases may occur in open market, privately negotiated transactions, or via Rule 10b5-1 plans.
Timing, price, and volume depend on market conditions and securities laws; program can be discontinued anytime.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.